Janney Montgomery Scott’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.84M | Buy |
13,000
+578
| +5% | +$324K | 0.01% | 827 |
|
|
2026
Q1 | $6.98M | Buy |
12,422
+211
| +2% | +$135K | 0.02% | 710 |
|
|
2025
Q4 | $8.26M | Sell |
12,211
-21,586
| -64% | -$14.7M | 0.02% | 692 |
|
|
2025
Q3 | $21.6M | Sell |
33,797
-1,530
| -4% | -$929K | 0.05% | 347 |
|
|
2025
Q2 | $18.9M | Sell |
35,327
-8,459
| -19% | -$4.05M | 0.05% | 350 |
|
|
2025
Q1 | $18.4M | Buy |
43,786
+3,728
| +9% | +$1.62M | 0.05% | 356 |
|
|
2024
Q4 | $16.6M | Buy |
+40,058
| New | +$17.6M | 0.05% | 391 |
|
|
2024
Q3 | – | Sell |
-39,880
| Closed | -$19.4M | – | 2750 |
|
|
2024
Q2 | $19.4M | Buy |
39,880
+5,461
| +16% | +$2.74M | 0.06% | 339 |
|
|
2024
Q1 | $18.6M | Buy |
34,419
+1,078
| +3% | +$589K | 0.06% | 351 |
|
|
2023
Q4 | $18.5M | Buy |
33,341
+4,130
| +14% | +$1.94M | 0.06% | 321 |
|
|
2023
Q3 | $12.8M | Buy |
29,211
+649
| +2% | +$324K | 0.05% | 359 |
|
|
2023
Q2 | $14.3M | Buy |
28,562
+1,764
| +7% | +$845K | 0.05% | 352 |
|
|
2023
Q1 | $13.4M | Buy |
26,798
+17,499
| +188% | +$8.37M | 0.05% | 326 |
|
|
2022
Q4 | $3.79M | Sell |
9,299
-16,238
| -64% | -$6.3M | 0.01% | 771 |
|
|
2022
Q3 | $8.32M | Buy |
25,537
+352
| +1% | +$129K | 0.04% | 447 |
|
|
2022
Q2 | $8.82M | Buy |
25,185
+2,939
| +13% | +$1.2M | 0.04% | 395 |
|
|
2022
Q1 | $12.2M | Sell |
22,246
-467
| -2% | -$246K | 0.05% | 329 |
|
|
2021
Q4 | $15M | Sell |
22,713
-1,673
| -7% | -$1.05M | 0.06% | 295 |
|
|
2021
Q3 | $15.2M | Buy |
24,386
+669
| +3% | +$450K | 0.06% | 269 |
|
|
2021
Q2 | $15M | Buy |
23,717
+2,023
| +9% | +$1.12M | 0.07% | 270 |
|
|
2021
Q1 | $10.6M | Buy |
21,694
+13,852
| +177% | +$6.94M | 0.05% | 316 |
|
|
2020
Q4 | $3.92M | Buy |
7,842
+664
| +9% | +$297K | 0.02% | 616 |
|
|
2020
Q3 | $2.82M | Buy |
7,178
+665
| +10% | +$246K | 0.02% | 665 |
|
|
2020
Q2 | $2.15M | Buy |
6,513
+2,107
| +48% | +$610K | 0.01% | 746 |
|
|
2020
Q1 | $1.07M | Sell |
4,406
-142
| -3% | -$37.1K | 0.01% | 913 |
|
|
2019
Q4 | $1.19M | Sell |
4,548
-2,288
| -33% | -$603K | 0.01% | 998 |
|
|
2019
Q3 | $1.86M | Buy |
6,836
+191
| +3% | +$53.1K | 0.01% | 787 |
|
|
2019
Q2 | $1.83M | Buy |
6,645
+2,033
| +44% | +$501K | 0.01% | 776 |
|
|
2019
Q1 | $1.03M | Sell |
4,612
-766
| -14% | -$158K | 0.01% | 1005 |
|
|
2018
Q4 | $1M | Sell |
5,378
-809
| -13% | -$166K | 0.01% | 928 |
|
|
2018
Q3 | $1.54M | Buy |
6,187
+2,243
| +57% | +$544K | 0.01% | 810 |
|
|
2018
Q2 | $860K | Sell |
3,944
-44
| -1% | -$9.07K | 0.01% | 1064 |
|
|
2018
Q1 | $763K | Sell |
3,988
-886
| -18% | -$164K | 0.01% | 1093 |
|
|
2017
Q4 | $762K | Buy |
4,874
+627
| +15% | +$98.7K | 0.01% | 1084 |
|
|
2017
Q3 | $660K | Buy |
4,247
+325
| +8% | +$51.4K | 0.01% | 1116 |
|
|
2017
Q2 | $633K | Buy |
3,922
+792
| +25% | +$129K | 0.01% | 1079 |
|
|
2017
Q1 | $484K | Buy |
3,130
+87
| +3% | +$12K | 0.01% | 1176 |
|
|
2016
Q4 | $357K | Sell |
3,043
-2,621
| -46% | -$299K | 0.01% | 1228 |
|
|
2016
Q3 | $639K | Buy |
+5,664
| New | +$597K | 0.01% | 840 |
|
Other funds holding IDXX
Janney Montgomery Scott's IDXX Position: Q2 2026 in Review
Janney Montgomery Scott increased its Idexx Laboratories (IDXX) stake by 4.7% in Q2 2026, buying an estimated $324K and bringing the position to 13,000 shares worth $6.84M. The position accounts for 0.01% of the portfolio, ranked #827.
Janney Montgomery Scott first reported a position in IDXX in Q3 2016 and has held it in 39 quarters since. The position peaked at $21.6M in Q3 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Janney Montgomery Scott held 13,000 shares of Idexx Laboratories worth $6.84M as of Q2 2026.
- Janney Montgomery Scott bought 578 Idexx Laboratories shares in Q2 2026, an estimated $324K.
- Idexx Laboratories made up 0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #827 holding.
- Janney Montgomery Scott first reported a position in Idexx Laboratories in Q3 2016 and has held it in 39 quarters since.
- Janney Montgomery Scott's Idexx Laboratories position peaked at $21.6M in Q3 2025.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.